Scoping Review: Perbandingan Cure Rate Obat-obat Antiskabies di Formularium Nasional dengan Non Formularium Nasional

Rizki Amalia Nashuha, Satryo Waspodo, Yani Triyani

Abstract


Abstract. Scabies is a skin disease that is caused by Sarcoptes scabiei var hominis mite. In Indonesia, scabies is the third of the 12 most common skin disease. Eleven factors can influence scabies prevalence, failure of treatment is one of the factors. This research aims to understand the comparison of antiscabietic drugs in National Formulary with Non-National Formulary. The method of this research is a scoping review that was done in September 2020–December 2020. The systematic search was done from electronic databases i.e. PubMed, Science Direct, Springerlink, Google Scholar, and Cochrane. Per the inclusion and exclusion criteria and PICOS (Patient, Intervention, Comparison, Outcome, and Study) criteria. From database searches, 17 articles are included. From 17 articles, 12 articles show that Permethrin has better cure rate than Benzyl Benzoate, Ivermectin, Gamma benzene hexachloride and Crotamiton. Two articles show that Ivermectin has higher cure rate than Lindane and Sulfur. One article suggests sulfur combination therapy is preferable to single therapy. One article shows that Tinospora cordifolia has a high cure rate. One article shows that Afoxolaner can be used as an antiscabies drug. The conclusion is that Permethrin has a high cure rate, so Permethrin can be used as the main therapy for scabies.

Keyword: Antiscabietic drugs, National Formulary, Scabies

Abstrak. Skabies adalah penyakit kulit yang disebabkan oleh tungau Sarcoptes scabiei var hominis. Di Indonesia, Skabies merupakan urutan ketiga dari 12 penyakit kulit tersering. Terdapat sebelas faktor yang bisa memengaruhi prevalensi skabies di suatu komunitas salah satunya adalah kegagalan pengobatan. Penelitian ini bertujuan untuk mengetahui perbandingan cure rate obat-obat antiskabies di Formularium Nasional dengan Non formularium Nasional. Metode pada penelitian ini adalah scoping review yang dilakukan dari September 2020–Desember 2020. Pencarian sistematis dilakukan melalui database elektronik yaitu PubMed, Science Direct, Springer Link, Google Scholar, dan Cochrane. Sesuai dengan kriteria inklusi dan eksklusi serta dilakukan skrining menggunakan kriteria PICOS (Pasien, Intervention, Comparison, Outcome, dan Study). Dari hasil pencarian, terdapat 17 artikel yang sesuai dengan kriteria. Dari 17 artikel, 12 artikel menunjukan bahwa Permethrin merupakan obat yang memiliki cure rate lebih baik daripada Benzyl Benzoate, Ivermectin, Gamma benzene hexachloride dan Crotamiton. Dua artikel menunjukan Ivermectin memiliki cure rate lebih tinggi daripada Lindane dan Sulfur. Satu artikel menunjukan terapi kombinasi sulfur lebih baik daripada terapi tunggal. Satu artikel menunjukan bahwa Tinospora cordifolia memiliki cure rate yang tinggi. Satu artikel menunjukan bahwa Afoxolaner dapat dijadikan obat antiskabies. Sehingga, dapat disimpulkan bahwa cure rate Permethrin tinggi, sehingga Permethrin dapat dijadikan terapi utama untuk skabies.

Kata kunci: Obat antiskabies, Formularium Nasional, Skabies


Keywords


Obat antiskabies, Formularium Nasional, Skabies

References


Mading M, Indriaty I. Kajian Aspek Epidemiologi Skabies pada Manusia. J Penyakit Bersumber Binatang. 2015;2(2):9–18.

World Health Organization. Scabies and other ectoparasites. Neglected tropical diseases. Tersedia di: https://www.who.int/water_sanitation_health/diseases-risks/diseases/scabies/en/

Putri YY, Dewi R, Astuti I, Bhatara T. Karakteristik Tanda Kardinal Penyakit Skabies pada Santri di Pesantren Characteristics of Cardinal Signs of Scabies in Santri at Islamic Boarding Schools. J Integ Kes Sains. 2020;2(3):126–9.

Bahrudin F, Djajakusumah TS, Susanti Y. Angka Kejadian dan Karakteristik Pasien Skabies di Rumah Sakit Al-Islam Bandung. Pros Pendidik Dr. 2015;0(0):1023–8. Dapat diunduh dari: http://karyailmiah.unisba.ac.id/index.php/dokter/article/view/1562/pdf

World Health Organization. Water-related Diseases. Water sanitation hygiene. Tersedia di: https://www.who.int/water_sanitation_health/diseases-risks/diseases/scabies/en/

Naftassa Z, Putri TR. Hubungan Jenis Kelamin, Tingkat Pendidikan Dan Pengetahuan Terhadap Kejadian Skabies Pada Santri Pondok Pesantren Qotrun Nada Kota Depok. Biomedika. 2018;10(2):115–9.

Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367(9524):1767–74.

Handayani N, Ikaditya L. Analisis Biaya Efektif Terapi Skabies Permetrin 5% Dan Salep 2-4. Media Inf. 2020;15(2):89–95.

Indonesia MKR. KEPMENKES Nomor HK.01.07/MENKES/813/2019 tentang Formularium Nasional. 2019. Dapat diunduh dari: https://iaijatim.id/kmk-no-hk-01-07-menkes-813-2019-ttg-formularium-nasional/

Khalil S, Abbas O, Kibbi AG, Kurban M. Scabies in the age of increasing drug resistance. PLoS Negl Trop Dis. 2017;11(11):1–10.

Chhaiya SB, Patel VJ, Dave JN, Mehta DS, Shah HA. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian J dermatology, Venerol Leprol. 2012;78(5):605–10.

Rao MA, Raza N, Faheem M, Saleem MA. Comparison Of Efficacy Of Permethrin 5% Cream With Crotamiton 10% Cream In Patients With Scabies. J Ayub Med Coll Abbottabad. 2019;31(2):230–2.

Meenakshi M, Sadhna K, Neeraj S, Deepak V, Renu P. An open label, randomized, comparative study of antiscabietic drugs permethrin, gamma benzene hexachloride and ivermectin in patients of uncomplicated scabies. Int J Pharmacol Clin Sci. 2014;3(2):15–21.

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass Drug Administration for Scabies Control in a Population with Endemic Disease. N Engl J Med. 2015;373(24):2305–13.

Alipour H, Goldust M. The efficacy of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies. Ann Parasitol. 2015;61(2):79–84.

Ranjkesh MR, Naghili B, Goldust M, Rezaee E. The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies. Ann Parasitol. 2013;59(4):189–94.

Sharma R, Singal A. Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study. Indian J dermatology, Venerol Leprol. 2011;77(5):581–6.

Pourhasan A, Goldust M, Rezaee E. Treatment of scabies, permethrin 5% cream vs. crotamiton 10% cream. Ann Parasitol. 2013;59(3):143–7.

Mila-Kierzenkowska C, Woźniak A, Krzyzyńska-Malinowska E, Kałuzna L, Wesołowski R, Poćwiardowski W, et al. Comparative efficacy of topical pertmehrin, crotamiton and sulfur ointment in treatment of scabies. J Arthropod Borne Dis. 2017;11(1):1–9.

Zaelany AI, Astuti ISW, Sutejo IR. Comparison of the Effectiveness of 10% Sulfur Soap and 2-4 Ointment as Single Treatment. J Agromedicine Med Sci. 2017;3(3):19.

Goldust M, Rezaee E, Raghifar R, Naghavi-Behzad M. Ivermectin vs. lindane in the treatment of scabies. Ann Parasitol. 2013;59(1):37–41.

Goldust M, Rezaee E, Raghifar R, Hemayat S. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Ann Parasitol. 2013;59(2):79–84.

Goldust M, Rezaee E, Raghifar R, Naghavi-Behzad M. Comparison of permethrin 2.5 % cream vs. Tenutex emulsion for the treatment of scabies. Ann Parasitol. 2013;59(1):31–5.

Goldust M, Alipour H. Permethrin 5% cream versus oral afoxolaner for the treatment of scabies a prospective, randomized, controlled, clinical trial study. Australas J Dermatol. 2019;60(S1):14–106.

Chitti Babu G, Bagati KD, Agarwal P, Sharda S. A comparative study to assess the efficacy of permethrin (Topical) and ivermectin (oral) in scabies patients seeking care at a tertiary care teaching hospital of Northern India. Int J Res Pharm Sci. 2020;11(1):1155–9.

Chitti Babu G, Bagati KD, Agarwal P, Sharma J. A comparative study to assess the efficacy of permethrin (topical) and benzyl benzoate (topical) for the treatment of scabies patients. Int J Res Pharm Sci. 2019;10(4):3688–93.

Castillo AL, Osi MO, Ramos JDA, De Francia JL, Dujunco MU, Quilala PF. Efficacy and safety of Tinospora cordifolia lotion in Sarcoptes scabiei var hominis-infected pediatric patients: A single blind, randomized controlled trial. J Pharmacol Pharmacother. 2013;4(1):39–46.




DOI: http://dx.doi.org/10.29313/kedokteran.v7i1.26746

Flag Counter